US 11,807,888 B2
Production of steviol glycoside in recombinant hosts
Kim Olsson, Frederiksberg (DK); Ernesto Simon, Copenhagen (DK); Michael Dalgaard Mikkelsen, Vaerlose (DK); Simon Carlsen, Reinach (CH); Veronique Douchin, Frederiksberg (DK); Swee Chuang Lim, Vallensbaek Strand (DK); and Louis During, Copenhagen (DK)
Assigned to EVOLVA SA, Reinach (CH)
Filed by EVOLVA SA, Reinach (CH)
Filed on Apr. 29, 2021, as Appl. No. 17/243,904.
Application 16/434,202 is a division of application No. 15/541,686, granted, now 10,364,450, issued on Jul. 30, 2019, previously published as PCT/EP2016/052007, filed on Jan. 29, 2016.
Application 17/243,904 is a continuation of application No. 16/434,202, filed on Jun. 7, 2019, granted, now 11,041,183.
Claims priority of provisional application 62/110,207, filed on Jan. 30, 2015.
Prior Publication US 2023/0033436 A1, Feb. 2, 2023
Int. Cl. C12P 19/56 (2006.01); C12N 9/10 (2006.01); C12P 15/00 (2006.01); C07H 15/256 (2006.01)
CPC C12P 19/56 (2013.01) [C07H 15/256 (2013.01); C12N 9/1051 (2013.01); C12P 15/00 (2013.01); C12Y 204/01 (2013.01)] 1 Claim
 
1. A steviol glycoside compound, wherein the compound is a tetra-glycosylated steviol compound 4.26 according to the following structure:

OG Complex Work Unit Chemistry
or an isomer thereof.